1. Home
  2. ULBI vs ONCY Comparison

ULBI vs ONCY Comparison

Compare ULBI & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ultralife Corporation

ULBI

Ultralife Corporation

HOLD

Current Price

$5.92

Market Cap

97.6M

Sector

Miscellaneous

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.89

Market Cap

112.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULBI
ONCY
Founded
1990
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Pharmaceuticals and Biotechnology
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.6M
112.5M
IPO Year
1995
2002

Fundamental Metrics

Financial Performance
Metric
ULBI
ONCY
Price
$5.92
$0.89
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.33
AVG Volume (30 Days)
23.9K
1.3M
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$191,159,000.00
N/A
Revenue This Year
$20.00
N/A
Revenue Next Year
N/A
$2,505.00
P/E Ratio
N/A
N/A
Revenue Growth
16.24
N/A
52 Week Low
$4.90
$0.33
52 Week High
$9.51
$1.51

Technical Indicators

Market Signals
Indicator
ULBI
ONCY
Relative Strength Index (RSI) 34.38 41.83
Support Level $5.18 $0.82
Resistance Level $6.14 $1.14
Average True Range (ATR) 0.45 0.08
MACD -0.15 -0.01
Stochastic Oscillator 11.69 13.48

Price Performance

Historical Comparison
ULBI
ONCY

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: